GHK-Cu for Dogs — Canine Skin & Coat Research Guide

GHK-Cu is not FDA-approved for use in dogs. Research (largely preclinical animal) studies and veterinary case use suggest it is generally well tolerated at conservative doses, but dog-specific safety data is limited. Known side effects in dogs are usually mild (injection-site reaction, copper load with prolonged use). Always get your dog cleared by a veterinarian first — especially with conditions like pregnancy, cancer, or autoimmune disease.

Canine research dosing for GHK-Cu is roughly 40 mcg per kg of body weight, once daily, by the subcutaneous or topical route — which works out to approximately 1 mg – 2 mg per dose depending on the dog's size. Size examples: Small (~5 kg): 1 mg · Medium (~15 kg): 1 mg · Large (~30 kg): 1.2 mg · Giant (~50 kg): 2 mg. Small breeds dose at the low end; giant breeds stay conservative. This is a research reference, not a dosing instruction — your veterinarian should confirm any amount.

No — never use human doses on dogs. Human peptide doses are far higher than canine doses for most compounds, and dog metabolism differs from ours in ways that matter. The vial may be the same compound, but the concentration, volume, and dose must be calculated for your dog's weight. If a veterinarian agrees to supervise GHK-Cu use, they should specify the exact dose and reconstitution for your dog.

Typical canine research cycles are 8 weeks, followed by 4 weeks off. Course-based bioregulators (GHK-Cu in some uses) deliberately run short courses with long breaks. Cycling gives the body a reset window and mirrors how these peptides are used in veterinary practice. Do not run continuous open-ended cycles.

Reported/expected effects in dogs are usually mild: Injection-site reaction, Copper load with prolonged use, Rare GI upset (oral). Because dogs cannot report how they feel, watch appetite, energy, stool quality, and behavior daily. Call your veterinarian if vomiting or diarrhea lasts over 24 hours, food is refused for more than one meal, or you see pale gums, spreading swelling, or any sudden behavior change.

Contraindicated for: pregnant; nursing; puppies under 1 year; copper storage disease; liver disease; copper toxicity. Breed-specific caution: bedlington/doberman/labrador/west highland/dalmatian-type breeds — This breed is prone to copper storage hepatopathy. GHK-Cu adds a copper load — do not use it in copper-storage-prone breeds without explicit veterinary approval. When in doubt, ask your veterinarian before starting anything new.

GHK-Cu evidence level: Preclinical (animal data). No human clinical trials — based on preclinical/animal data (laboratory studies, some canine-specific). For skin & coat in dogs specifically, most dosing is extrapolated from laboratory studies and limited veterinary use rather than controlled canine clinical trials.